Misrepresenting Race – The Role of Medical Schools in Propagating Physician Bias

January 6, 2021

The New England Journal of Medicine

Read the full article

Authors

Amutah C, Greenidge K, Mante A, Munyikwa M, Surya SL, Higginbotham E, Jones DS, Lavizzo-Mourey R, Roberts D, Tsai J, Aysola J

CHIBE Experts

Jaya Aysola MD, DTMH, MPH

Research Areas

Measuring Quality-Weighted Hospital-Free-Days in Acute Respiratory Failure: A Modified Delphi Study

Annals of the American Thoracic Society

March 20, 2024
Field Testing the Transferability of Behavioural Science Knowledge on Promoting Vaccinations

Nature Human Behaviour

March 14, 2024
The Impact of Health Care Algorithms on Racial and Ethnic Disparities : A Systematic Review

Annals of Internal Medicine

March 12, 2024
Perspectives of Black Patients on Racism Within Emergency Care

JAMA Health Forum

March 8, 2024
The Next Decade of Healthcare

Healthcare

February 29, 2024
Health Care Resource Utilization and Costs Associated With Diagnosed Medication Overuse Headache and Potential Acute Medication Overuse in Individuals With Migraine

Cephalalgia

February 27, 2024
Evaluating the Implementation of a Community Health Worker-Delivered Intervention Integrating Asthma Care in West Philadelphia Public Schools

Journal of Asthma

February 9, 2024
Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting

Clinical Lymphoma Myeloma Leukemia

February 8, 2024
A Social Network Analysis of Hemodialysis Clinics: Attitudes Towards Living Donor Kidney Transplant Among Influential Patients

Kidney360

February 7, 2024
Differential Hospital Participation in Bundled Payments in Communities with Higher Shares of Marginalized Populations

Journal of General Internal Medicine

February 6, 2024
Officer-Involved Killings of Unarmed Black People and Racial Disparities in Sleep Health

JAMA Internal Medicine

February 5, 2024
Real-World Analysis of Adverse Event Rates After Initiation of Ibrutinib Among Medicare Beneficiaries With Chronic Lymphocytic Leukemia

Cancer Medicine

February 1, 2024